Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) Stock Information | RedChip

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP)


$12.8300
-0.1700 ( -1.69% ) 92.2K

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company'sĀ development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Market Data


Open


$12.8300

Previous close


$13.0000

Volume


92.2K

Market cap


$157.42M

Day range


$12.6850 - $13.4700

52 week range


$5.3000 - $61.9000

SEC Filings


Form Type Description Pages Date
8-k 8K-related 87 Aug 06, 2024
10-q Quarterly Reports 79 Aug 06, 2024
8-k 8K-related 12 Aug 06, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
8-k 8K-related 11 Jun 17, 2024
4 Insider transactions 2 Jun 14, 2024
4 Insider transactions 2 Jun 03, 2024
4 Insider transactions 2 Jun 03, 2024
4 Insider transactions 2 Jun 03, 2024

Latest News